Year-end Sale % OFF 
Abstract
Background and Aims: Type 2 Diabetes Mellitus (DM2) is associated with important disturbances in lipoprotein metabolism. There is little evidence regarding the effect of sodium-glucose co-transporter 2 (SGLT-2) inhibitors and dipeptidyl-peptidase 4 (DPP-4) inhibitors on serum lipid metabolism. The aim of the study was to compare the effects of dapagliflozin and sitagliptin on serum lipid and apolipoprotein-B containing lipoprotein subfraction concentrations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
